House Study Bill 172 HOUSE FILE BY (PROPOSED COMMITTEE ON HUMAN RESOURCES BILL BY CHAIRPERSON SMITH) Passed House, Date Passed Senate, Date Vote: Ayes Nays Vote: Ayes Nays Approved A BILL FOR 1 An Act relating to the substitution of antiepileptic drugs and 2 establishing an effective date. 3 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA: 4 TLSB 2108YC 82 5 jr/je/5 PAG LIN 1 1 Section 1. Section 155A.32, Code 2007, is amended by 1 2 adding the following new subsection: 1 3 NEW SUBSECTION. 4. The pharmacist shall not exercise the 1 4 drug product selection described in this section for an 1 5 antiepileptic drug or formulation of an antiepileptic drug, 1 6 brand or generic name, prescribed for the treatment of 1 7 seizures, including epilepsy, without prior notification of 1 8 and the signed informed consent of that selection from both 1 9 the authorized prescriber and the patient or the patient's 1 10 representative. 1 11 Sec. 2. EFFECTIVE DATE. This Act, being deemed of 1 12 immediate importance, takes effect upon enactment. 1 13 EXPLANATION 1 14 Current law allows a pharmacist to exercise professional 1 15 judgment by selecting a drug product with the same generic 1 16 name and demonstrated bioavailability as the drug prescribed 1 17 for dispensing and sale to the patient. This bill limits that 1 18 discretion in the case of an antiepileptic drug prescribed by 1 19 brand or generic name. Prior to any substitution the 1 20 pharmacist must obtain signed informed consent of that 1 21 selection from both the authorized prescriber and the patient 1 22 or the patient's representative. 1 23 The board of pharmacy examiners may impose a variety of 1 24 penalties for violation of the bill, as set out in Code 1 25 section 272C.3. In addition, civil penalties not to exceed 1 26 $25,000 may be imposed. 1 27 The bill is made effective upon enactment. 1 28 LSB 2108YC 82 1 29 jr:nh/je/5